Stanley P. Balcerzak

Medicine · Health Sciences

36h-index4.7kcitations108works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(13), Sarcoma Diagnosis and Treatment(13), Iron Metabolism and Disorders(13), Hemoglobinopathies and Related Disorders(12), Acute Myeloid Leukemia Research(11)

Publications108 total

A Phase I and Pharmacokinetic Study of Weekly Oxaliplatin Followed by Paclitaxel in Patients with Solid Tumors
Clinical Cancer Research·2008· 11 cited
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)
American Journal of Hematology·2007· 29 citedOpen Access
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study
Investigational New Drugs·2004· 1 cited
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study
Investigational New Drugs·2004· 3 cited
A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer
Breast Cancer Research and Treatment·2004· 16 cited
Health Status and Quality of Life in Patients With Early-Stage Hodgkin’s Disease Treated on Southwest Oncology Group Study 9133
Journal of Clinical Oncology·2003· 99 cited
High‐dose ifosfamide with mesna and granuloctye–colony‐stimulating factor (recombinant human G‐CSF) in patients with unresectable malignant mesothelioma
Cancer·2003· 5 citedOpen Access
Combination of Fludarabine and Mitoxantrone in Untreated Stages III and IV Low-Grade Lymphoma: S9501
Journal of Clinical Oncology·2003· 51 cited
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia
Blood·2002· 220 citedOpen Access
Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat
Cancer Chemotherapy and Pharmacology·2002· 16 cited
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study
Blood·2002· 192 citedOpen Access
Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients
Cancer Chemotherapy and Pharmacology·2002· 28 cited
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.
PubMed·2002· 509 cited
A Phase II Study of Topotecan in Non-Hodgkin's Lymphoma: An Ohio State University Phase II Research Consortium Study
Cancer Investigation·2002· 14 cited
A Phase II Study of CI-980 in Previously Untreated Extensive Small Cell Lung Cancer: An Ohio State University Phase II Research Consortium Study
Cancer Investigation·2002· 16 cited
Infusional CHOP Chemotherapy (CVAD) With or Without Chemosensitizers Offers No Advantage Over Standard CHOP Therapy in the Treatment of Lymphoma: A Southwest Oncology Group Study
Journal of Clinical Oncology·2001· 29 cited
COMBINATION CISPLATIN, 5-FLUOROURACIL AND RADIATION THERAPY FOR LOCALLY ADVANCED UNRESECTABLE OR MEDICALLY UNFIT BLADDER CANCER CASES: A SOUTHWEST ONCOLOGY GROUP STUDY
The Journal of Urology·2001· 70 cited
Interferon Alfa Consolidation After Intensive Chemotherapy Does Not Prolong the Progression-Free Survival of Patients With Low-Grade Non-Hodgkin’s Lymphoma: Results of the Southwest Oncology Group Randomized Phase III Study 8809
Journal of Clinical Oncology·2000· 81 cited
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma
Cancer·2000· 109 cited
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma
Cancer·2000· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Arthur L. Sagone(6), Albert F. LoBuglio(6), Earl N. Metz(6), Richard I. Fisher(4), Kenneth K. Chan(3), Cheryl L. Willman(3), Frederick R. Appelbaum(3), John J. Rinehart(3), Laurence H. Baker(3), Ellen R. Gaynor(3), Donald V. Unverferth(3), Carl V. Leier(3), Thomas P. Miller(3), Robert M. OʼBryan(3), James A. Neidhart(3), Maxwell P. Westerman(3), Daniel D. Von Hoff(3), Charles A. Coltman(3), Rebecca Brooks(2), Kenneth J. Kopecky(2)